Medtech Pharma: China March 2019

Register your interest

Applications have now closed for this trade mission. Register with us and keep up to date for any future trade missions, or propose your own.

The Trade Mission will comprise a program of site visits, business networking and opportunities for participating delegates to develop relationships with key players in China’s Medtech Pharma sector.

It is proposed that this mission will start in Shanghai where delegates will participate in the AusBio Invest Forum before travelling to the Greater Bay Area (Guangzhou and Shenzhen) and finishing in Chengdu. Delegates may participate in all or part of the program.

China is emerging as a significant market for Medtech and Pharma, with Pharmaceutical sales in China expected to rise from USD$108B in 2016, to USD$167B by 2020.

By 2022, it is expected that China’s annual growth rate, which currently averages 30 per cent of biomedical R&D will surpass the USA. The Greater Bay Area in particular presents significant opportunities for Medtech and Pharma companies. The Greater Bay area in China accommodates 68 million people with a total GDP output of US$1.4 trillion and been identified as an emerging commercial powerhouse to rival Silicon Valley.

Key dates

Mission dates: Wednesday 27 March to Thursday 4 April 2019
Locations: Shanghai, Chengdu and Greater Bay Area, China

Applications have now closed

Want to know more?

For further information about this trade mission, contact Libby O'Connor by sending her an email